| Name | Title | Contact Details |
|---|---|---|
Jamie Sischo |
Vice President Contracts and Proposals and Government Business Development | Profile |
Asif Sayani |
General Counsel | Profile |
We design and manufacture functional and sustainable applications for human and veterinary immobilization and mobility.
PBM consulting, provider nnetwork strategies, rebate benchmarking, global drug sourcing, client pricing, market assessments, MAC management, rebate aggregation.
Get relief from depression in under 8 weeks. Safe & FDA approved. Covered by Insurance & Medicare. Get your FREE consultation. Book an appointment Today!
Ophthotech is a biopharmaceutical company specializing in the development of novel therapeutics to treat back of the eye diseases, with a focus on developing innovative therapies for age-related macular degeneration (AMD). Ophthotech`s most advanced product candidate, Fovista® anti-PDGF therapy, is in Phase 3 clinical trials for use in combination with anti-VEGF therapy that represents the current standard of care for the treatment of wet AMD. Ophthotech`s second product candidate, Zimura®, an inhibitor of complement factor C5, is being developed for the treatment of geographic atrophy, a form of dry AMD.
Greater Nashua Mental Health believes in empowering people to lead full and satisfying lives through effective treatment and support.